Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$1.0 - $1.39 $68,491 - $95,202
-68,491 Reduced 82.32%
14,708 $16,000
Q2 2023

Aug 14, 2023

SELL
$2.95 - $4.44 $621,305 - $935,117
-210,612 Reduced 71.68%
83,199 $325,000
Q1 2023

May 15, 2023

BUY
$2.94 - $4.18 $516,419 - $734,229
175,653 Added 148.66%
293,811 $967,000
Q4 2022

Feb 14, 2023

BUY
$2.73 - $3.7 $322,571 - $437,184
118,158 New
118,158 $344,000
Q2 2022

Aug 15, 2022

BUY
$2.22 - $4.54 $54,025 - $110,485
24,336 Added 132.59%
42,690 $95,000
Q1 2022

May 16, 2022

SELL
$3.58 - $4.98 $65,796 - $91,527
-18,379 Reduced 50.03%
18,354 $77,000
Q4 2021

Feb 14, 2022

BUY
$4.17 - $7.09 $101,514 - $172,598
24,344 Added 196.5%
36,733 $176,000
Q3 2021

Nov 15, 2021

SELL
$5.87 - $7.85 $2,336 - $3,124
-398 Reduced 3.11%
12,389 $74,000
Q2 2021

Aug 16, 2021

SELL
$6.69 - $9.0 $127,023 - $170,883
-18,987 Reduced 59.76%
12,787 $96,000
Q1 2021

May 17, 2021

BUY
$8.26 - $11.4 $22,814 - $31,486
2,762 Added 9.52%
31,774 $263,000
Q4 2020

Feb 16, 2021

BUY
$8.21 - $18.59 $238,188 - $539,333
29,012 New
29,012 $246,000
Q3 2020

Nov 16, 2020

SELL
$11.33 - $19.81 $615,513 - $1.08 Million
-54,326 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$4.2 - $15.45 $56,771 - $208,837
13,517 Added 33.12%
54,326 $619,000
Q1 2020

May 14, 2020

BUY
$3.38 - $10.63 $137,934 - $433,799
40,809 New
40,809 $179,000

Others Institutions Holding MESO

About MESOBLAST LTD


  • Ticker MESO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 147,316,000
  • Market Cap $1.2B
  • Description
  • Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines in the United States, Australia, Singapore, the United Kingdom, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its ...
More about MESO
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.